XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (shares) at Jan. 31, 2024       3,263,659 33,655,756      
Beginning balance at Jan. 31, 2024 $ (153,546)     $ 3 $ 34 $ 1,252,200 $ (180) $ (1,405,603)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         1,111,795      
Vesting of restricted stock units 1       $ 1      
Issuance of common stock under employee stock purchase plan (shares)         143,206      
Issuance of common stock under employee stock purchase plan 1,121         1,121    
Stock-based compensation expense 15,196         15,196    
Other comprehensive income (loss) (246)           (246)  
Net loss (26,007)             (26,007)
Ending balance (shares) at Apr. 30, 2024       3,263,659 34,910,757      
Ending balance at Apr. 30, 2024 (163,481)     $ 3 $ 35 1,268,517 (426) (1,431,610)
Beginning balance (shares) at Jan. 31, 2024       3,263,659 33,655,756      
Beginning balance at Jan. 31, 2024 (153,546)     $ 3 $ 34 1,252,200 (180) (1,405,603)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units 1       $ 1      
Net loss (64,258) $ (5,484) $ (58,774)          
Ending balance (shares) at Oct. 31, 2024       3,263,659 35,841,729      
Ending balance at Oct. 31, 2024 (171,170)     $ 3 $ 36 1,298,596 56 (1,469,861)
Beginning balance (shares) at Apr. 30, 2024       3,263,659 34,910,757      
Beginning balance at Apr. 30, 2024 (163,481)     $ 3 $ 35 1,268,517 (426) (1,431,610)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         486,654      
Shares repurchased for tax withholdings on vesting of restricted stock (shares)         (30,204)      
Shares repurchased for tax withholdings on vesting of restricted stock (208)         (208)    
Stock-based compensation expense 16,472         16,472    
Other comprehensive income (loss) 346           346  
Net loss (19,490)             (19,490)
Ending balance (shares) at Jul. 31, 2024       3,263,659 35,367,207      
Ending balance at Jul. 31, 2024 (166,361)     $ 3 $ 35 1,284,781 (80) (1,451,100)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         386,507      
Shares repurchased for tax withholdings on vesting of restricted stock (shares)         (42,119)      
Shares repurchased for tax withholdings on vesting of restricted stock (296)         (296)    
Issuance of common stock under employee stock purchase plan (shares)         130,134      
Issuance of common stock under employee stock purchase plan 789         789    
Stock-based compensation expense 13,322         13,322    
Other comprehensive income (loss) 136           136  
Net loss (18,761) $ (1,577) $ (17,184)         (18,761)
Ending balance (shares) at Oct. 31, 2024       3,263,659 35,841,729      
Ending balance at Oct. 31, 2024 (171,170)     $ 3 $ 36 1,298,596 56 (1,469,861)
Beginning balance (shares) at Jan. 31, 2025   3,263,659 36,190,448 3,263,659 36,190,448      
Beginning balance at Jan. 31, 2025 (177,246)     $ 3 $ 36 1,310,922 (669) (1,487,538)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         696,803      
Vesting of restricted stock units 1       $ 1      
Shares repurchased for tax withholdings on vesting of restricted stock (shares)         (58,691)      
Shares repurchased for tax withholdings on vesting of restricted stock (486)         (486)    
Issuance of common stock under employee stock purchase plan (shares)         112,108      
Issuance of common stock under employee stock purchase plan 680         680    
Stock-based compensation expense 15,042         15,042    
Other comprehensive income (loss) 1,359           1,359  
Net loss (18,052)             (18,052)
Ending balance (shares) at Apr. 30, 2025       3,263,659 36,940,668      
Ending balance at Apr. 30, 2025 (178,702)     $ 3 $ 37 1,326,158 690 (1,505,590)
Beginning balance (shares) at Jan. 31, 2025   3,263,659 36,190,448 3,263,659 36,190,448      
Beginning balance at Jan. 31, 2025 (177,246)     $ 3 $ 36 1,310,922 (669) (1,487,538)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Net loss (51,372) $ (4,128) $ (47,244)          
Ending balance (shares) at Oct. 31, 2025   3,263,659 38,534,833 3,263,659 38,534,833      
Ending balance at Oct. 31, 2025 (191,932)     $ 3 $ 39 1,346,653 283 (1,538,910)
Beginning balance (shares) at Apr. 30, 2025       3,263,659 36,940,668      
Beginning balance at Apr. 30, 2025 (178,702)     $ 3 $ 37 1,326,158 690 (1,505,590)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         1,114,948      
Vesting of restricted stock units 1       $ 1      
Shares repurchased for tax withholdings on vesting of restricted stock (shares)         (88,147)      
Shares repurchased for tax withholdings on vesting of restricted stock (1,119)         (1,119)    
Stock-based compensation expense 11,488         11,488    
Other comprehensive income (loss) (222)           (222)  
Net loss (22,932)             (22,932)
Ending balance (shares) at Jul. 31, 2025       3,263,659 37,967,469      
Ending balance at Jul. 31, 2025 (191,486)     $ 3 $ 38 1,336,527 468 (1,528,522)
Increase (Decrease) in Stockholders' Equity (Deficit) [Roll Forward]                
Vesting of restricted stock units (shares)         522,755      
Vesting of restricted stock units 1       $ 1      
Shares repurchased for tax withholdings on vesting of restricted stock (shares)         (61,968)      
Shares repurchased for tax withholdings on vesting of restricted stock (1,128)         (1,128)    
Issuance of common stock under employee stock purchase plan (shares)         106,577      
Issuance of common stock under employee stock purchase plan 653         653    
Stock-based compensation expense 10,601         10,601    
Other comprehensive income (loss) (185)           (185)  
Net loss (10,388) $ (818) $ (9,570)         (10,388)
Ending balance (shares) at Oct. 31, 2025   3,263,659 38,534,833 3,263,659 38,534,833      
Ending balance at Oct. 31, 2025 $ (191,932)     $ 3 $ 39 $ 1,346,653 $ 283 $ (1,538,910)